Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NYSE /
  3. NVRO.NYSE

Nevro Corp (NVRO NYSE) stock market data APIs

$10.14 0.4(4.1%) as of July 26, 2024
Price chart is built with Anychart

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Nevro Corp Financial Data Overview

9.74
10.14
-
10.14
9.62
7.46-25.45
363 M
36 729 K
431 M
-0.58
0.909
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NVRO',
Type: 'Common Stock',
Name: 'Nevro Corp',
Exchange: 'NYSE',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001K61W36',
ISIN: NULL,
CUSIP: NULL,
CIK: '1444380',
EmployerIdNumber: '56-2568057',
FiscalYearEnd: 'December',
IPODate: '2014-11-06',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Medical Devices',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Nevro Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 431 M
  • EBITDA -87 049 000
  • Earnings Per Share -2.28
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Nevro Corp Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -1.05

Get Nevro Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Nevro Corp latest news via APIs

Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024

REDWOOD CITY, Calif., July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today ...

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

REDWOOD CITY, Calif., June 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pa...
Do you have any questions?
support@eodhistoricaldata.com